The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
1% zuo mei mo si ru gao lian he hong lan guang zhi liao mian bu zhi yi xing pi yan de liao xiao guan cha
Author(s): 
Pages: 89-91
Year: Issue:  2
Journal: Southern China Journal of Dermato-Venereology

Keyword:  吡美莫司红蓝光脂溢性皮炎;
Abstract: 目的:观察1%吡美莫司乳膏联合红蓝光治疗面部脂溢性皮炎的疗效与安全性.方法:收集2015年4月至2016年4月至我院皮肤科门诊就诊符合脂溢性皮炎诊断标准的患者108例,随机分为两组.治疗组54例采用吡美莫司乳膏联合红蓝光治疗;对照组54例仅采用吡美莫司乳膏治疗.均在治疗6周后进行临床评分判定疗效.结果:治疗结束后,两组治疗前后自身对照比较,差异均有统计学意义(P<0.05).治疗组治疗后临床症状积分低于对照组(t=-5.16,P<0.05),临床疗效优于对照组(X2=4.82,P<0.05),差异均具有统计学意义.两组患者均未出现严重不良反应.结论:1% 吡美莫司乳膏联合红蓝光联合治疗面部脂溢性皮炎疗效确切,安全性高,在临床上具有一定的推广价值.
Related Articles
No related articles found